Physician profile
David M Light
NPI 1366647828
$2,353.80
in general payments reported to CMS, 2019-2025
14 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 77% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $104 · 2021: $41.14 · 2022: $188 · 2023: $85.12 · 2024: $343 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,200 · Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,200.00 |
| Food and Beverage | $602.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $1,200.00 | 2025 | |
| Axogen | $306.29 | 2021-2025 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Abbvie INC. | $139.77 | 2023-2025 | |
| Tactile Systems Technology INC | $129.34 | 2024 | Flexitouch Plus, Entre Plus |
| Sientra, INC. | $122.69 | 2019-2022 | |
| Allergan, INC. | $106.59 | 2019-2022 | |
| Tela Bio, INC. | $106.04 | 2019 | |
| Merck Sharp & Dohme LLC | $57.33 | 2023-2024 | Bridion |
| Integra Lifesciences Corporation | $47.06 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $39.29 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Biocomposites INC | $28.15 | 2025 | Stimulan |
| Kci USA, INC. | $27.06 | 2020 | |
| Baxter Healthcare | $23.41 | 2019 | |
| Mentor Worldwide LLC | $20.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.